BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36467989)

  • 1. Prognostic Value of Inflammation-Immunity-Nutrition Score and Inflammatory Burden Index for Hepatocellular Carcinoma Patients After Hepatectomy.
    Song R; Ni H; Huang J; Yang C; Qin S; Wei H; Luo J; Huang Y; Xiang B
    J Inflamm Res; 2022; 15():6463-6479. PubMed ID: 36467989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic significance of inflammation-immunity-nutrition score on postoperative survival and recurrence in hepatocellular carcinoma patients.
    Liang Y; Zhang Z; Zhong D; Lai C; Dai Z; Zou H; Feng T; Shang J; Shi Y; Huang X
    Front Oncol; 2022; 12():913731. PubMed ID: 36016629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of inflammation-immunity-nutrition score in patients with hepatocellular carcinoma treated with anti-PD-1 therapy.
    Zhang Z; Liang Y; Zhong D; Dai Z; Shang J; Lai C; Zou H; Yao Y; Feng T; Huang X
    J Clin Lab Anal; 2022 May; 36(5):e24336. PubMed ID: 35312116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Nomogram Model for Predicting Recurrence of Stage I-III Endometrial Cancer Based on Inflammation-Immunity-Nutrition Score (IINS) and Traditional Classical Predictors.
    Jiang P; Wang J; Gong C; Yi Q; Zhu M; Hu Z
    J Inflamm Res; 2022; 15():3021-3037. PubMed ID: 35645577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Nomogram Model Based on the Inflammation-Immunity-Nutrition Score (IINS) and Classic Clinical Indicators for Predicting Prognosis in Extranodal Natural Killer/T-Cell Lymphoma.
    He Y; Luo Z; Chen H; Ping L; Huang C; Gao Y; Huang H
    J Inflamm Res; 2024; 17():2089-2102. PubMed ID: 38595337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
    Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
    Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of γ-glutamyl transpeptidase to albumin ratio combined with aspartate aminotransferase to lymphocyte ratio in patients with hepatocellular carcinoma after hepatectomy.
    Liu KJ; Lv YX; Niu YM; Bu Y
    Medicine (Baltimore); 2020 Nov; 99(48):e23339. PubMed ID: 33235099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.
    Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L
    Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Percutaneous Thermal Ablation Combined With Transarterial Embolization for Recurrent Hepatocellular Carcinoma After Hepatectomy and a Prognostic Nomogram to Predict Survival.
    Yuan Z; Wang Y; Hu C; Gao W; Zheng J; Li W
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818801362. PubMed ID: 30244651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of nomogram models of inflammatory markers based on clinical database to predict prognosis for hepatocellular carcinoma after surgical resection.
    Mao S; Yu X; Sun J; Yang Y; Shan Y; Sun J; Mugaanyi J; Fan R; Wu S; Lu C
    BMC Cancer; 2022 Mar; 22(1):249. PubMed ID: 35255845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-institutional validation of novel models for predicting the prognosis of patients with huge hepatocellular carcinoma.
    Wang XH; Liu QB; Xiang CL; Mao XH; Yang B; Li Q; Zhou QF; Li SQ; Zhou ZG; Chen MS
    Int J Cancer; 2021 Jul; 149(1):127-138. PubMed ID: 33586134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
    Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
    World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic prediction by a novel integrative inflammatory and nutritional score based on least absolute shrinkage and selection operator in esophageal squamous cell carcinoma.
    Feng J; Wang L; Yang X; Chen Q; Cheng X
    Front Nutr; 2022; 9():966518. PubMed ID: 36438741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Prognostic Nomograms Based on Inflammation-Related Markers for Patients with Hepatocellular Carcinoma Underwent Hepatectomy.
    Wang Y; Sun K; Shen J; Li B; Kuang M; Cao Q; Peng S
    Cancer Res Treat; 2019 Oct; 51(4):1464-1478. PubMed ID: 30913869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining Pre- and Postoperative Lymphocyte-C-Reactive Protein Ratios Can Better Predict Hepatocellular Carcinoma Prognosis After Partial Hepatectomy.
    Ni HH; Lu Z; Huang X; Ning SW; Liang XL; Zhang SY; Xiang BD
    J Inflamm Res; 2022; 15():2229-2241. PubMed ID: 35411168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel prognostic nomogram based on microvascular invasion and hematological biomarkers to predict survival outcome for hepatocellular carcinoma patients.
    Li X; Huang H; Yu X; Chen P; Ouyang J; Huang B
    Surg Oncol; 2020 Jun; 33():51-57. PubMed ID: 32561099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative C-reactive protein/albumin ratio to predict mortality and recurrence of patients with hepatocellular carcinoma after curative resection.
    Ren Y; Fan X; Chen G; Zhou D; Lin H; Cai X
    Med Clin (Barc); 2019 Sep; 153(5):183-190. PubMed ID: 30606506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative Systemic Immune-Inflammation Index (SII) as a Superior Predictor of Long-Term Survival Outcome in Patients With Stage I-II Gastric Cancer After Radical Surgery.
    He K; Si L; Pan X; Sun L; Wang Y; Lu J; Wang X
    Front Oncol; 2022; 12():829689. PubMed ID: 35296020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma.
    Lin WP; Xing KL; Fu JC; Ling YH; Li SH; Yu WS; Zhang YF; Zhong C; Wang JH; Chen ZY; Lu LH; Wei W; Guo RP
    JAMA Netw Open; 2021 Sep; 4(9):e2125055. PubMed ID: 34515782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy.
    Ruan DY; Lin ZX; Li Y; Jiang N; Li X; Wu DH; Wang TT; Chen J; Lin Q; Wu XY
    World J Gastroenterol; 2015 May; 21(18):5598-606. PubMed ID: 25987785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.